Literature DB >> 3442237

Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity.

O Simonsen1, K Kjeldsen, M W Bentzon, I Heron.   

Abstract

The need for routine diphtheria revaccination is still controversial. Only single cases of diphtheria have been observed in Denmark since the mass vaccinations in the 1940s and the introduction of routine vaccination of infants in 1950, despite the fact that general revaccination has not been recommended. An investigation of antitoxin immunity in 1.188 probands 2-69 years of age, randomly or cluster selected, indicated that immunity in the Danish population is still above the limit generally believed to guard against diphtheria epidemics (around 70% being immune in a population). The highest frequency of susceptibility (46%) was found among females 30-39 years of age. Serum antitoxin concentrations in 529 subjects with documentation for complete primary vaccination 1-40 years previously corresponded to a continuous fall-off. Relative to time from vaccination, individuals born when diphtheria occurred frequently in Denmark had significantly higher antitoxin levels than those born later, and among children susceptibility had increased considerably as compared to observations in the 1950s. These phenomena were explained by the effect of natural immune stimulation previously. The present concept of relatively high frequencies of immune subjects also in other western countries may not be valid in the future, when the number of subjects born after the elimination of indigenous diphtheria increases. General revaccinations seem required to maintain herd immunity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3442237     DOI: 10.1111/j.1699-0463.1987.tb00035.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  6 in total

1.  Serological survey on the immunity to diphtheria of the northern Greek population.

Authors:  E Souliou; V Kyriazopoulou; E Diza; M Hatzistylianou; F Frantzidou
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Immunity to diphtheria in northern Norway and northwestern Russia.

Authors:  P A Jenum; V Skogen; E Danilova; A Eskild; H Sjursen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

3.  Long-term persistence of anti-diphtheria toxin antibodies among adults in Israel. Implications for vaccine policy.

Authors:  D Cohen; M S Green; E Katzenelson; R Slepon; H Bercovier; M Wiener
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

4.  Immunity to diphtheria in adults in England.

Authors:  E Miller; M Rush; P Morgan-Capner; D Hutchinson; L Hindle
Journal:  BMJ       Date:  1994-02-26

5.  The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV).

Authors:  P Laroche; M Barrand; S C Wood; K Van Hasbrouck; J Lang; E Harzer; L Hessel
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 7.455

Review 6.  Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses.

Authors:  Mark K Slifka; Ian J Amanna
Journal:  Front Immunol       Date:  2019-05-01       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.